ClinicalTrials.gg
RecruitingNCT06214208Updated Oct 30, 2025

Influence of Spinal Stimulation Frequency on Spasticity, Motor Control, and Pain After Spinal Cord Injury

An interventional study of Transcutaneous Spinal Stimulation in Spinal Cord Injuries, sponsored by Shepherd Center, Atlanta GA. Recruiting at 1 site in United States. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2025-10-30.

Sponsored by Shepherd Center, Atlanta GA · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Feb 2024; still recruiting 2 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Spinal Cord Injuries by Shepherd Center, Atlanta GA — 2 open to participants now, 2 under way, none of them phase 3. Spinal Cord Injuries · Shepherd Center, Atlanta GA.

Planned enrollment
5th of 14
36 · median 20
Started
2024
the only one that year
No phase
14 of 14
2 open now
Registered
13th of 14
by date

Among the 14 studies in Spinal Cord Injuries by Shepherd Center, Atlanta GA, this one is the 5th largest by planned enrollment, is the only one that started in 2024, is one of 14 with no phase, and was the 13th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

2 of the 14 studies in Spinal Cord Injuries by Shepherd Center, Atlanta GA are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 16 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Spinal Cord Injuries by Shepherd Center, Atlanta GA, or all of them as a file.
02

Study summary

The goal of this study is to identify the effect of different types of noninvasive spinal stimulation on spasticity (involuntary muscle activity), muscle strength, and pain in people with spinal cord injury. The spinal stimulation consists of electrical stimulation applied through one electrode over the skin of the lower back and two electrodes over the stomach. Testing will include participating in measurements before the intervention, during intervention, and immediately after the intervention. This study requires participants to come into Shepherd Center 4 consecutive days a week for 2-3 hours per day across 2-3 weeks.

Read the detailed description

Transcutaneous spinal stimulation (TSS) is a noninvasive electrical stimulation that is applied over the skin of the low back and stomach. In prior research studies, TSS has reduced spasticity without the negative side effects of drug therapies. Although research in TSS is growing, the best dosage of TSS remains unknown. The investigators want to further advance the effects of TSS by comparing three different frequencies. Frequency is the number of electrical pulses that are delivered over a period of time. Frequency can affect the activation of nerves and therefore affect the outcome of TSS. Participation in this study includes testing of the participants' spasticity, strength, and pain before and after 30 minutes of TSS.

03

Conditions studied

  • Spinal Cord Injuries
04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants must agree to allow use of health information.
  • Participants should be 16 years old or older.
  • Participants must have had a spinal cord injury (SCI) of any severity (AIS A, B, C, or D) that happened at least 3 months ago.
  • Objectively measurable spasticity in your legs.
  • Participants must inform the investigators if there is a change in medications during the study.
  • Participants must be able to follow instructions.
  • Participants must be able to communicate if pain or discomfort is experienced.

Exclusion criteria

Exclusion Criteria:

  • People with spinal issues that are getting worse, such as degenerative or progressive vascular disorders.
  • People neurological problems other than SCI.
  • People with an injury level is below T12.
  • People with un-treated or uncontrolled heart problems that the lead investigator believes could be affected by stimulation or affected by an increase in blood pressure.
  • People with bone or joint problems that would make it hard to follow the study plan.
  • Women who are pregnant or actively trying to become pregnant.
  • People with implanted stimulators (like a baclofen pump, spinal stimulator, heart defibrillator, or diaphragmatic pacemaker)
  • People with infection.
  • People with skin that is broken or wounds in the area of the body where stimulation is applied.
  • People who have or had certain types of cancer in the area of the body where stimulation will be applied.
  • People who have had botulinum toxin or numbing shots in the test leg or spine in the last 6 months
  • People who have had permanent spasticity treatment in the test leg or spine (like a certain type of surgery).
  • Other health issues that the lead investigator things could make it unsafe for you to join the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    30 Hz Frequency

    Intervention will be applied with a 30 Hz frequency.

    Other: Transcutaneous Spinal Stimulation

  • Experimental
    50 Hz Frequency

    Intervention will be applied with a 50 Hz frequency.

    Other: Transcutaneous Spinal Stimulation

  • Experimental
    80 Hz Frequency

    Intervention will be applied with an 80 Hz frequency.

    Other: Transcutaneous Spinal Stimulation

Interventions

  • OtherTranscutaneous Spinal Stimulation

    Transcutaneous spinal stimulation will be delivered for 30 minutes using biphasic pulses. A single cathode electrode will be placed over the skin of the back spine at the T11/T12 spinous interspace. Two reference electrodes will be placed over the stomach. Stimulation intensity will be set to 0.8x reflex threshold, as determined by posterior root muscle reflex testing before the intervention. Treatments will be a minimum of 72 hours apart.

06

What researchers measure

Primary outcomes

  1. Pendulum Test

    During the pendulum test, the participant will be lying on a therapy mat with the lower leg hanging off the edge of the mat. A member of the study staff will support the participant's extended lower leg and then release the leg allowing it to swing freely. This test will be video recorded and the movement of the knee joint will be measured using software on the computer.

    Time frame: 15 minutes

Secondary outcomes

  1. Ankle Clonus Test

    During the ankle clonus test, the participant will be seated at the edge of a mat with the lower leg hanging over the mat. A member of the study staff will support the participant's leg above a box and then release the leg allowing the front of the foot to land on the edge of the box. This test will be video recorded and the movement of the ankle joint will be measured using software on the computer.

    Time frame: 15 minutes

  2. Muscle activation

    Participants will be asked to activate different leg muscles and produce the maximum amount of force possible. Muscle activation will be measured through sensors placed on the muscles and force production will be measured using a dynamometer.

    Time frame: 20 minutes

  3. Posterior root muscle reflexes

    Posterior root muscle reflexes will be used to measure spinal reflex excitability. These reflexes will also be used to determine the intensity of stimulation that is applied during the intervention (0.8x soleus reflex threshold). During this test, participants have a single electrode over the skin of the back (T11/12) and two electrodes over the stomach (umbilicus). Brief pulses of stimulation will be applied at gradually increasing intensities while measuring muscle responses in different leg muscles.

    Time frame: 25 minutes

  4. Nociception/Pain

    The investigators will measure nociception using the flexor reflex. The flexor reflex measures muscle responses to an unpleasant stimulus. Electrodes will be placed at the bottom of the foot. First, the investigators will measure muscle responses to a single stimulus (25 mA). Next, the investigators will measure muscle responses to 5 consecutive stimuli (25 mA). The investigators will then ask participants to rate the unpleasant stimulus on a scale of 0-10.

    Time frame: 15 minutes

  5. Quality of Spasticity Questionnaire

    The Qualities of Spasticity Survey is a self-report questionnaire that asks participants about the physical qualities of their spasticity and how it impacts daily life. Participants will be asked to report experience with spasticity over the past 48 hours.

    Time frame: 5 minutes

  6. Modified Penn Spasm Frequency Scale

    The Modified Penn Spasm Frequency Scale is a self-report questionnaire that asks participants to rate the frequency and severity of spasms during the last hour.

    Time frame: 2 minutes

  7. Stimulation Tolerability Questionnaire

    Participants will be asked to rate how tolerable the spinal stimulation was during the session and to describe specific sensations that contributed to this rating.

    Time frame: 2 minutes

  8. Global Rating of Change Scale

    Participants will be asked to rate how much their change in spasticity affects their daily life.

    Time frame: 1 minute

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2024 (actual). Primary completion is estimated for Dec 2026, 33 months after the start.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 33 months is below that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 9, 2024
First posted
Jan 19, 2024
StartActual
Feb 19, 2024
Primary completionEst.
Dec 15, 2026
CompletionEst.
Dec 15, 2026
Last update
Oct 30, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06214208
Lead sponsor
Shepherd Center, Atlanta GA
Responsible party
Edelle Field-Fote, PT, PhD (Director, Spinal Injury Research & The Hulse Spinal Injury Laboratory, Shepherd Center, Atlanta GA) — Principal investigator
First posted
Jan 19, 2024
Start date
Feb 19, 2024
Primary completion
Dec 15, 2026 (estimated)
Completion
Dec 15, 2026 (estimated)
Last update
Oct 30, 2025

Study contacts

Jaclyn Miller, PT, DPT
Contact
jaclyn.miller@shepherd.org
404-350-7638
Evan Sandler, PT, DPT
Contact
evan.sandler@shepherd.org
404-603-4175
Edelle C Field-Fote, PT, PhD
principal investigator · Shepherd Center, Atlanta GA

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion